Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Journal of Gastroenterology
Erschienen in: Journal of Gastroenterology 8/2010

01.08.2010 | Review

Gastroesophageal reflux disease

verfasst von: Kwong Ming Fock, Choo Hean Poh

Erschienen in: Journal of Gastroenterology | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

GERD is a common chronic gastrointestinal disorder, and its prevalence in Asia is increasing. Classical symptoms of heartburn and regurgitation are common presentations. There is no standard criterion for the diagnosis of GERD, and 24-h pH monitoring lacks sensitivity in NERD. Furthermore, diagnostic studies for gastroesophageal reflux disease have several limitations. A short course of PPI is often used in clinical practice as a diagnostic test for gastroesophageal reflux disease. Elderly patients with GERD usually present with atypical manifestations, and they tend to develop more severe disease. PPI remains the mainstay of treatment for GERD. In a subset of patients who wish to discontinue maintenance treatment, anti-reflux surgery is a therapeutic option.
Literatur
1.
Dent J, El Serag H, Wallender M, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.CrossRefPubMed
2.
Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543–52.CrossRefPubMed
3.
Fock KM, Talley NJ, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004;19:357–67.CrossRefPubMed
4.
Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hung R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23:8–22.CrossRefPubMed
5.
Nimish V, Sander V, Kahrilas P, Dent J, Jones R, Global Consensus Group. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.CrossRef
6.
Tack J, Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder? Aliment Pharmacol Ther. 2004;19(Suppl 1):28–34.CrossRefPubMed
7.
Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastroesophageal reflux disease. Lancet. 1990;335:205–8.CrossRefPubMed
8.
Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.CrossRefPubMed
9.
Ho KY, Gwee KA, Khor JL, Selamat DS, Yeoh KG. Validation of a graded response questionnaire for the diagnosis of gastroesophageal reflux disease in an Asian primary care population. J Clin Gastroenterol. 2008;42:680–6.CrossRefPubMed
10.
Wu W. Ancillary tests in the diagnosis of gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990;19:671–82.PubMed
11.
Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management—the Geneval Workshop Report. Gut. 1999;44:S1–16.CrossRef
12.
Yoshikawa I, Yamasaki M, Yamasaki T, Kume K, Otsuki M. Lugol chromoendoscopy as a diagnostic tool in so called endoscopy negative GERD. Gastrointest Endosc. 2005;62:698–703. (see also pp 752, 754).CrossRefPubMed
13.
Sharma P, Wani S, Bansal A, Hall S, Puli S, Mathur S, Rastogi A. A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:454–64.CrossRefPubMed
14.
Fock KM, Teo EK, Ang TL, Tan JY, Law NM. The utility of narrow band imaging in improving the endoscopic diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:54–9.CrossRefPubMed
15.
Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2007;5:4–16.CrossRefPubMed
16.
Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated Intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13–22.CrossRefPubMed
17.
Armstrong D, Vieth M, Fiocca R, Deprez P, Kuipers E, Holmqinst L, et al. Are endoscopy negative GERD and reflux esophagitis different disease? Baseline histology in GERD patients off-therapy—the CHEER Study. Gastroenterology. 2003;124:A-416.
18.
Vakil N. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastroesophageal reflux disease? Aliment Pharmacol Ther. 2005;22(Suppl 1):64–9.CrossRefPubMed
19.
Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD. Does it still have a role? J Clin Gastroenterol. 2008;42:867–74.CrossRefPubMed
20.
Fass R, Ofman J, Sampliner R, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24 hour esophageal pH monitoring in diagnosing gastroesophageal reflux disease in symptomatic patients with erosive esophagitis. Aliment Pharmacol Ther. 2000;14:389–96.CrossRefPubMed
21.
Euler A, Byrne W. Twenty-four hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology. 1981;80:957–61.PubMed
22.
Fass R, Fennerty M, Ofman JJ, Gralnek IM, Johnson C, Camargo E, et al. The clinical and economic value of a short course of omeprazole in patients with non-cardiac chest pain. Gastroenterology. 1998;115:42–9.CrossRefPubMed
23.
Martinez S, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD)-acid reflux and symptom pattern. Aliment Pharmacol Ther. 2003;17:537–45.CrossRefPubMed
24.
Des Varannes SB, Mion F, Ducrotte P, Zerbib F, Denis P, Ponchon T, et al. Simultaneous recording of esophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682–6.CrossRefPubMed
25.
Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastroesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non acid and gas reflux. Gut. 2004;53:1024–31.CrossRefPubMed
26.
Bredenoord AJ, Weusten BLAM, Timmer R, Conchillo JM, Smout AJPM. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006;101:453–9.CrossRefPubMed
27.
Lichtenstein DR, Cash BD, Davila R, Baron TH, Adler DG, Anderson MA, et al. Standards of Practice Committee. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007;66:219–24.CrossRefPubMed
28.
Poh CH, Gasiorowska A, Navarro-Rodriguez T, Willis MR, Hargadon D, Noelck N, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71:28–34.CrossRefPubMed
29.
Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965–71.CrossRefPubMed
30.
Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux esophagitis. Scand J Gastroenterol. 1989;24:401–6.CrossRefPubMed
31.
Carling L, Cronstedt J, Engqvist A, Kagevi I, Nyström B, Svedberg LE, et al. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study. Scand J Gastroenterol. 1988;23:1117–24.CrossRefPubMed
32.
Tytgat GNJ. Review article: treatment of mild and severe cases of GERD. Aliment Pharmacol Ther. 2002;16(Suppl 4):73–8.CrossRefPubMed
33.
Colin-Jones DG. The role and limitations of H2-receptor antagonists in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1995;9(Suppl 1):9–14.PubMed
34.
Chiba N, De Gara CJ, Wilkinson JM, Hunt R. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798–810.CrossRefPubMed
35.
DeVault KR, Castell DO. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 1999;94:1434–42.CrossRefPubMed
36.
Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastroesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol. 1998;10:119–24.CrossRefPubMed
37.
Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long term treatment of reflux esophagitis. Gastroenterology. 1994;107:1305–11.PubMed
38.
Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1994;48:91–132.CrossRefPubMed
39.
Koury SI, Stone CK, La Charite DD. Omeprazole and the development of acute hepatitis. Eur J Emerg Med. 1998;5:467–9.CrossRefPubMed
40.
Yip D, Kovac S, Jardine M, Horvath J, Findlay M. Omeprazole induced interstitial nephritis. J Clin Gastroenterol. 1997;25:450–2.CrossRefPubMed
41.
Singh P, Indaram A, Greenberg R, Visvalingam V, Bank S. Long term omeprazole therapy for reflux esophagitis: follow up in serum gastrin levels, EC cell hyperplasia and neoplasia. World J Gastroenterol. 2000;6:789–92.PubMed
42.
Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidrogrel. CMAJ. 2009;180:713–8.PubMed
43.
Futagami S, Iwakiri K, Shindo T, Kawagoe T, Horie A, Shimpuku M, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol. 2010;45:413–21.CrossRefPubMed
44.
Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, et al. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol. 2005;11(27):4210–4.PubMed
45.
Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547–52.CrossRefPubMed
46.
Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post prandial gastroesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003;17:243–51.CrossRefPubMed
47.
Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Thor K, Lamm M, et al. Long term management of gastroesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. Eur J Gastroenterol Hepatol. 2000;12:879–87.CrossRefPubMed
48.
Lafullarde T, Watson D, Jamieson G, Meyers JC, Game PA, Devitt PG. Laparoscopic Nissen fundoplication. Arch Surg. 2001;136:180–4.CrossRefPubMed
49.
Spechler S. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786–92.CrossRefPubMed
50.
Lundell L, Attwood S, Fiocca R, Galmiche JP, Hatlebakk J, Lind T, et al. Comparison laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastroesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut. 2008;57:1207–13.CrossRefPubMed
51.
Kozarek R, Low D, Raltz S. Complications associated with laparoscopic anti-reflux surgery: one multispecialty clinic’s experience. Gastrointest Endosc. 1997;46:527–31.CrossRefPubMed
52.
Galmiche J, Zerbib F. Laparoscopic fundoplication is the treatment of choice for gastroesophageal reflux disease. Gut. 2002;51:472–4.CrossRefPubMed
53.
Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A, et al. Seven-year follow-up of randomized clinical trial comparing proton pump inhibition with surgical therapy for reflux esophagitis. Br J Surg. 2007;94:198–203.CrossRefPubMed
54.
Soot S, Eshraghi N, Farahmand M, Sheppard BC, Deveney CW. Transition from open to laparoscopic fundoplication: the learning curve. Arch Surg. 1999;134:278–81.CrossRefPubMed
55.
DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976;184:459–70.CrossRefPubMed
56.
Poh CH, Allen L, Gasiorowska A, Navarro-Rodriguez T, Quan SF, Malagon I, et al. Conscious awakening are commonly associated with acid-reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2010 (in press).
57.
Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, et al. A comparison of omeprazole and ranitidine in the prevention of reoccurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology. 1994;107:1312–8.PubMed
58.
Raiha IJ, Imprivaara O, Seppala M, Sourander LB. Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly. J Am Geriatr Soc. 1992;40:1209–11.PubMed
59.
Zhu H, Pace F, Sangaletti O, Bianchi PG. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol. 1993;28:235–8.CrossRefPubMed
60.
Plant RL. Anatomy and physiology of swallowing in adults and geriatrics. Otolaryngol Clin North Am. 1998;31:447–88.
61.
Raiha I, Hietanen E, Sourander L. Symptoms of gastro-esophageal reflux disease in elderly people. Age Ageing. 1991;20:365–70.CrossRefPubMed
62.
Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence for gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol. 1991;86:965–70.PubMed
63.
O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778–81.CrossRefPubMed
64.
Yang YX, Lewis JD, Epstein S, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947–53.CrossRefPubMed
65.
Laheij RJF, Stukenboom MCJM, Hassing RJ, Dieleman J, Stricker BHC, Jansen JBMJ. Risk of community-acquired pneumonia and use of gastric acid suppressive drugs. JAMA. 2004;292:1955–60.CrossRefPubMed
Metadaten
Titel
Gastroesophageal reflux disease
verfasst von
Kwong Ming Fock
Choo Hean Poh
Publikationsdatum
01.08.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 8/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0274-9

Weitere Artikel der Ausgabe 8/2010

Journal of Gastroenterology 8/2010 Zur Ausgabe

Original Article—Alimentary Tract

Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn’s disease: relevance to local angiotensin II system

Original Article—Liver, Pancreas, and Biliary Tract

Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly

Original Article—Liver, Pancreas, and Biliary Tract

Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease

Original Article—Liver, Pancreas, and Biliary Tract

CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma

Original Article—Alimentary Tract

Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population

Review

Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise